- Home
- BDTX
as 12-18-2024 9:46am EST
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 144.9M | IPO Year: | 2020 |
| Target Price: | $15.50 | AVG Volume (30 days): | 476.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.31 - $7.66 | Next Earning Date: | 11-05-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Black Diamond Therapeutics Inc. News
BDTX Breaking Stock News: Dive into BDTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks
Associated Press Finance
a month ago
Black Diamond: Q3 Earnings Snapshot
Simply Wall St.
a month ago
Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks
GlobeNewswire
a month ago
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2 months ago
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
MT Newswires
2 months ago
Black Diamond Cuts Programs, Workforce to Save Funding for Prospective Lung Cancer Therapy
GlobeNewswire
2 months ago
Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
Benzinga
3 months ago
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
Compare BDTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDTX Black Diamond Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.